SIRT7 expression also affects breast cancer progression and metastasis deacetylating SMAD4 and, consequentially, determining its degradation through β-transducin repeat-containing protein (β-TrCP1), while its deficiency is linked to transforming growth factor β (TGF-β) pathway activation enhancing metastatic process [60]. This evidence concerns the gene SIRT7 and breast carcinoma.